Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis.
Early and Degressive Putamen Atrophy in Multiple Sclerosis.
Analysis of the direct injury effector of oligodendroglia cells or myelin sheath in an experimental allergic encephalomyelitis model induced by the MOG35-55 peptide.
Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis.
Multiple sclerosis: Efficacy of fingolimod confirmed on all MRI end points.
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?
Complex assessment in progressive multiple sclerosis: a case report.
Multiple deep white matter lesions mimicking multiple sclerosis as an unusual complication of a left atrial myxoma.
The Bioenergetic Health Index: a new concept in mitochondrial translational research.
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
Constraint-Induced Movement Therapy for the Lower Extremities in Multiple Sclerosis: Case Series with 4-Year Follow-up.
Frequency of reported European ancestry among multiple sclerosis patients from four cities in the southern and southeastern regions of Brazil.
General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
Evoked potentials in multiple sclerosis.
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies.
Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge.
Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients.
Leuprolide Acetate, a GnRH Agonist, Improves Experimental Autoimmune Encephalomyelitis: A Possible Therapy for Multiple Sclerosis.
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys.
Leg spasticity and ambulation in multiple sclerosis.

Pages